FiEE, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that FiEE, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2020 | Dec 31, 2020 | $47.99M | Apr 13, 2021 |
| FY2020 | Dec 31, 2019 | $37.61M | Apr 13, 2021 |
| FY2019 | Dec 31, 2018 | $32.32M | Apr 15, 2020 |
| FY2018 | Dec 31, 2017 | $29.42M | Apr 1, 2019 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.19M | Mar 20, 2026 |
| FY2025 | Dec 31, 2024 | $639.9K | Mar 20, 2026 |
| FY2023 | Dec 31, 2023 | $26.11M | Jul 28, 2025 |
| FY2023 | Dec 31, 2022 | $50.62M | Jul 28, 2025 |
| FY2022 | Dec 31, 2021 | $55.42M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $47.99M | Aug 19, 2022 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.35M | Mar 20, 2026 |
| FY2025 | Dec 31, 2024 | $207.3K | Mar 20, 2026 |
| FY2023 | Dec 31, 2023 | $470.9K | Jul 28, 2025 |
| FY2023 | Dec 31, 2022 | $11.93M | Jul 28, 2025 |
| FY2022 | Dec 31, 2021 | $18.92M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $13.61M | Aug 19, 2022 |
| FY2020 | Dec 31, 2019 | $10.91M | Apr 13, 2021 |
| FY2019 | Dec 31, 2018 | $11.64M | Apr 15, 2020 |
| FY2018 | Dec 31, 2017 | $10.24M | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | $5.37M | Mar 30, 2018 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.07M | Mar 20, 2026 |
| FY2025 | Dec 31, 2024 | ($4.22M) | Mar 20, 2026 |
| FY2023 | Dec 31, 2023 | ($17.63M) | Jul 28, 2025 |
| FY2023 | Dec 31, 2022 | ($15.55M) | Jul 28, 2025 |
| FY2022 | Dec 31, 2021 | ($2.20M) | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | ($3.86M) | Aug 19, 2022 |
| FY2020 | Dec 31, 2019 | ($3.28M) | Apr 13, 2021 |
| FY2019 | Dec 31, 2018 | ($74.3K) | Apr 15, 2020 |
| FY2018 | Dec 31, 2017 | ($1.37M) | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | ($2.93M) | Mar 30, 2018 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.55M | Mar 20, 2026 |
| FY2025 | Dec 31, 2024 | ($4.24M) | Mar 20, 2026 |
| FY2023 | Dec 31, 2023 | ($17.21M) | Jul 28, 2025 |
| FY2023 | Dec 31, 2022 | ($15.05M) | Jul 28, 2025 |
| FY2022 | Dec 31, 2021 | ($1.93M) | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | ($4.82M) | Aug 19, 2022 |
| FY2020 | Dec 31, 2019 | ($3.22M) | Apr 13, 2021 |
| FY2019 | Dec 31, 2018 | $52.7K | Apr 15, 2020 |
| FY2018 | Dec 31, 2017 | ($1.21M) | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | ($2.88M) | Mar 30, 2018 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $47.4K | Mar 20, 2026 |
| FY2025 | Dec 31, 2024 | $113.3K | Mar 20, 2026 |
| FY2023 | Dec 31, 2023 | $3.45M | Jul 28, 2025 |
| FY2023 | Dec 31, 2022 | $5.82M | Jul 28, 2025 |
| FY2022 | Dec 31, 2021 | $6.16M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $3.83M | Aug 19, 2022 |
| FY2020 | Dec 31, 2019 | $2.24M | Apr 13, 2021 |
| FY2019 | Dec 31, 2018 | $1.77M | Apr 15, 2020 |
| FY2018 | Dec 31, 2017 | $1.94M | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | $1.52M | Mar 30, 2018 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.64M | Mar 20, 2026 |
| FY2025 | Dec 31, 2024 | ($3.77M) | Mar 20, 2026 |
| FY2023 | Dec 31, 2023 | $4.85M | Apr 10, 2025 |
| FY2023 | Dec 31, 2022 | ($12.17M) | Apr 12, 2024 |
| FY2022 | Dec 31, 2021 | ($14.27M) | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | ($7.09M) | Aug 19, 2022 |
| FY2020 | Dec 31, 2019 | ($1.54M) | Apr 13, 2021 |
| FY2019 | Dec 31, 2018 | ($1.80M) | Apr 15, 2020 |
| FY2018 | Dec 31, 2017 | $1.33M | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | ($4.21M) | Mar 30, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $186.1K | Mar 20, 2026 |
| FY2023 | Dec 31, 2023 | $162.3K | Apr 10, 2025 |
| FY2023 | Dec 31, 2022 | $276.7K | Apr 12, 2024 |
| FY2022 | Dec 31, 2021 | $593.1K | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $302.5K | Aug 19, 2022 |
| FY2020 | Dec 31, 2019 | $174.3K | Apr 13, 2021 |
| FY2019 | Dec 31, 2018 | $236.9K | Apr 15, 2020 |
| FY2018 | Dec 31, 2017 | $99.8K | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | $58.2K | Mar 30, 2018 |
| FY2016 | Dec 31, 2015 | $177.1K | Mar 22, 2017 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $10.77M | Mar 20, 2026 |
| FY2025 | Dec 31, 2024 | $307.0K | Mar 20, 2026 |
| FY2023 | Dec 31, 2023 | $12.36M | Jul 28, 2025 |
| FY2023 | Dec 31, 2022 | $30.96M | Jul 28, 2025 |
| FY2022 | Dec 31, 2021 | $54.30M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $29.61M | Aug 19, 2022 |
| FY2020 | Dec 31, 2019 | $13.90M | Apr 13, 2021 |
| FY2019 | Dec 31, 2018 | $12.22M | Apr 15, 2020 |
| FY2018 | Dec 31, 2017 | $8.79M | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | $9.02M | Mar 30, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.18M | Mar 20, 2026 |
| FY2025 | Dec 31, 2024 | $437.0K | Mar 20, 2026 |
| FY2023 | Dec 31, 2023 | $12.24M | Jul 28, 2025 |
| FY2023 | Dec 31, 2022 | $14.62M | Jul 28, 2025 |
| FY2022 | Dec 31, 2021 | $23.81M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $21.82M | Aug 19, 2022 |
| FY2020 | Dec 31, 2019 | $7.79M | Apr 13, 2021 |
| FY2016 | Dec 31, 2016 | $4.86M | Mar 22, 2017 |
| FY2016 | Dec 31, 2015 | $1.72M | Mar 22, 2017 |
| FY2015 | Dec 31, 2014 | $1.85M | Mar 15, 2016 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.59M | Mar 20, 2026 |
| FY2025 | Dec 31, 2024 | ($130.0K) | Mar 20, 2026 |
| FY2025 | Dec 31, 2023 | $115.9K | Mar 20, 2026 |
| FY2023 | Dec 31, 2022 | $16.34M | Jul 28, 2025 |
| FY2023 | Dec 31, 2021 | $30.49M | Jul 28, 2025 |
| FY2022 | Dec 31, 2020 | $7.79M | Mar 31, 2023 |
| FY2021 | Dec 31, 2019 | $6.11M | Aug 19, 2022 |
| FY2020 | Dec 31, 2018 | $3.88M | Apr 13, 2021 |
| FY2019 | Dec 31, 2017 | $3.17M | Apr 15, 2020 |
| FY2018 | Dec 31, 2016 | $4.16M | Apr 1, 2019 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Dec 31, 2021 | $58.9K | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $58.9K | Aug 19, 2022 |
| FY2020 | Dec 31, 2019 | $0 | Apr 13, 2021 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($95.62M) | Mar 20, 2026 |
| FY2025 | Dec 31, 2024 | ($96.69M) | Mar 20, 2026 |
| FY2023 | Dec 31, 2023 | ($92.47M) | Jul 28, 2025 |
| FY2023 | Dec 31, 2022 | ($74.83M) | Jul 28, 2025 |
| FY2022 | Dec 31, 2021 | ($59.29M) | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | ($57.09M) | Aug 19, 2022 |
| FY2020 | Dec 31, 2019 | ($40.60M) | Apr 13, 2021 |
| FY2019 | Dec 31, 2018 | ($37.32M) | Apr 15, 2020 |
| FY2018 | Dec 31, 2017 | ($37.25M) | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | ($35.88M) | Mar 30, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.08M | Mar 20, 2026 |
| FY2025 | Dec 31, 2024 | $30.2K | Mar 20, 2026 |
| FY2023 | Dec 31, 2023 | $709.3K | Jul 28, 2025 |
| FY2023 | Dec 31, 2022 | $530.1K | Jul 28, 2025 |
| FY2022 | Dec 31, 2021 | $12.57M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $771.8K | Aug 19, 2022 |
| FY2020 | Dec 31, 2019 | $1.22M | Apr 13, 2021 |
| FY2019 | Dec 31, 2018 | $126.0K | Apr 15, 2020 |
| FY2018 | Dec 31, 2017 | $229.2K | Apr 1, 2019 |
| FY2018 | Dec 31, 2016 | $179.8K | Apr 1, 2019 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 20, 2026 |
| FY2025 | Dec 31, 2024 | (1) | Mar 20, 2026 |
| FY2023 | Dec 31, 2023 | (8) | Jul 28, 2025 |
| FY2023 | Dec 31, 2022 | (8) | Jul 28, 2025 |
| FY2022 | Dec 31, 2021 | 0 | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | 0 | Aug 19, 2022 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 20, 2026 |
| FY2025 | Dec 31, 2024 | (1) | Mar 20, 2026 |
| FY2023 | Dec 31, 2023 | (8) | Jul 28, 2025 |
| FY2023 | Dec 31, 2022 | (8) | Jul 28, 2025 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 7.93M | Mar 20, 2026 |
| FY2025 | Dec 31, 2024 | 3.71M | Mar 20, 2026 |
| FY2023 | Dec 31, 2023 | 2.79M | Jul 28, 2025 |
| FY2023 | Dec 31, 2022 | 1.88M | Jul 28, 2025 |
| FY2022 | Dec 31, 2021 | 45.89M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | 35.07M | Aug 19, 2022 |
| FY2020 | Dec 31, 2019 | 20.93M | Apr 13, 2021 |
| FY2019 | Dec 31, 2018 | 16.12M | Apr 15, 2020 |
| FY2018 | Dec 31, 2017 | 15.29M | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | 14.69M | Mar 30, 2018 |